FDA Inspection 751754 — BioMarin Pharmaceutical, Inc.

BioMarin Pharmaceutical, Inc. — FEI 3004079983

The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on November 3, 2011 in Novato, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 3, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Novato, CA (United States)